Cargando…

Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased (1)H NMR-Linked Metabolomics Strategy

Biomarkers currently available for the diagnosis, prognosis, and therapeutic monitoring of GM1 gangliosidosis type 2 (GM1T2) disease are mainly limited to those discovered in targeted proteomic-based studies. In order to identify and establish new, predominantly low-molecular-mass biomarkers for thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Percival, Benita C., Latour, Yvonne L., Tifft, Cynthia J., Grootveld, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998791/ https://www.ncbi.nlm.nih.gov/pubmed/33807817 http://dx.doi.org/10.3390/cells10030572

Ejemplares similares

GM1 Gangliosidosis—A Mini-Review
por: Nicoli, Elena-Raluca, et al.
Publicado: (2021)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis
por: Latour, Yvonne L., et al.
Publicado: (2019)

GM1 Gangliosidosis: Mechanisms and Management
por: Rha, Allisandra K, et al.
Publicado: (2021)

A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis
por: Kell, Pamela, et al.
Publicado: (2023)

A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)
por: Davies, Elin Haf, et al.
Publicado: (2020)

GM1gangliosidosis: Clinical and radiological clue to diagnosis
por: Suthar, Renu, et al.
Publicado: (2012)

Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019)

GM1‐Gangliosidosis Type III Associated Parkinsonism
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2021)

Wishbone Sign in GM1 Type III Gangliosidosis
por: Agarwal, Ayush, et al.
Publicado: (2023)

Genetics and Therapies for GM2 Gangliosidosis
por: Cachón-González, María Begoña, et al.
Publicado: (2018)

Neuroradiological findings in GM2 gangliosidosis variant B1
por: Bano, Shahina, et al.
Publicado: (2011)

Clinical findings in Brazilian patients with adult GM1 gangliosidosis
por: Giugliani, Luciana, et al.
Publicado: (2019)

Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
por: Mehta, Sahil, et al.
Publicado: (2019)

Late-infantile GM1 gangliosidosis: A case report
por: Noh, Eu Seon, et al.
Publicado: (2022)

Benchtop Low-Frequency 60 MHz NMR Analysis of Urine: A Comparative Metabolomics Investigation
por: Leenders, Justine, et al.
Publicado: (2020)

Myelin Abnormalities in the Optic and Sciatic Nerves in Mice With GM1-Gangliosidosis
por: Heinecke, Karie A., et al.
Publicado: (2015)

Extensive Mongolian Spots in a Hypotonic Infant with GM1 Gangliosidosis
por: Ranjan, Suprabhat, et al.
Publicado: (2018)

Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part II: Applications to the Diagnosis and Prognostic Monitoring of Oral and Systemic Cancers
por: Grootveld, Martin, et al.
Publicado: (2022)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

Animal models of GM2 gangliosidosis: utility and limitations
por: Lawson, Cheryl A, et al.
Publicado: (2016)

GM1 GANGLIOSIDOSIS ASSOCIATED WITH NEONATAL-ONSET OF DIFFUSE ECCHYMOSES AND MONGOLIAN SPOTS
por: Dweikat, Imad, et al.
Publicado: (2011)

Genetic Analysis of Undiagnosed Juvenile GM1-Gangliosidosis by Microarray and Exome Sequencing
por: Bouhouche, Ahmed, et al.
Publicado: (2018)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

Cysts in White Matter: A Novel Neuroimaging Finding in Infantile GM1 Gangliosidosis
por: Kamate, Mahesh
Publicado: (2018)

Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients
por: Akar, Halil Tuna, et al.
Publicado: (2022)

GM1‐gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat
por: Bingaman, Amanda, et al.
Publicado: (2022)

Low-Field Benchtop NMR Spectroscopy for Quantification of Aldehydic Lipid Oxidation Products in Culinary Oils during Shallow Frying Episodes
por: Gibson, Miles, et al.
Publicado: (2023)

GM2 Gangliosidosis in Shiba Inu Dogs with an In‐Frame Deletion in HEXB
por: Kolicheski, A., et al.
Publicado: (2017)

GM1 gangliosidosis in a Japanese domestic cat: a new variant identified in Hokkaido, Japan
por: UENO, Hiroshi, et al.
Publicado: (2015)

Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
por: Tsunogai, Toshiki, et al.
Publicado: (2022)

Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis
por: Tsunogai, Toshiki, et al.
Publicado: (2022)

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
por: Clemente, Francesca, et al.
Publicado: (2022)

Serial MRI Features of Canine GM1 Gangliosidosis: A Possible Imaging Biomarker for Diagnosis and Progression of the Disease
por: Hasegawa, Daisuke, et al.
Publicado: (2012)

Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
por: Chen, Joseph C., et al.
Publicado: (2020)

Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation
por: Kajihara, Ryutaro, et al.
Publicado: (2020)

Protein modeling and clinical description of a novel in‐frame GLB1 deletion causing GM1 gangliosidosis type II
por: Richter, John E., et al.
Publicado: (2018)

AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves Survival
por: Baek, Rena C., et al.
Publicado: (2010)

Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity
por: Yang, Chi-Fan, et al.
Publicado: (2010)

Therapeutic Potential of Intracerebroventricular Replacement of Modified Human β-Hexosaminidase B for GM2 Gangliosidosis
por: Matsuoka, Kazuhiko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ojgo8jqi4rq56q503isnfpfg6